Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | -120,000 | -11,000 | -249,000 | 684,000 | 80,000 |
| Other Operating Activity | 2,201,000 | 1,774,000 | 1,985,000 | 1,454,000 | 2,096,000 |
| Operating Cash Flow | $2,081,000 | $1,763,000 | $1,736,000 | $2,138,000 | $2,176,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -303,000 | -382,000 | -261,000 | -493,000 | -151,000 |
| Net Acquisitions | -2,004,000 | -172,000 | -501,000 | -130,000 | 7,000 |
| Purchase Of Investment | -93,000 | -21,000 | -30,000 | -36,000 | -43,000 |
| Sale Of Investment | 49,000 | 36,000 | 202,000 | 915,000 | 16,000 |
| Purchase Sale Intangibles | -72,000 | 278,000 | -120,000 | -285,000 | N/A |
| Other Investing Activity | 18,000 | 376,000 | 44,000 | 55,000 | -860,000 |
| Investing Cash Flow | $-2,398,000 | $-238,000 | $-666,000 | $25,000 | $-1,031,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 619,000 | -637,000 | 166,000 | -1,213,000 | N/A |
| Debt Issued | 1,358,000 | 0 | 0 | 275,000 | 33,000 |
| Debt Repayment | -10,000 | -12,000 | -11,000 | -14,000 | 2,348,000 |
| Common Stock Issued | 4,000 | 1,000 | 18,000 | 13,000 | 15,000 |
| Common Stock Repurchased | -8,000 | 2,000 | -50,000 | -392,000 | -954,000 |
| Dividend Paid | -698,000 | -906,000 | -771,000 | -689,000 | -752,000 |
| Other Financing Activity | 51,000 | -587,000 | -6,000 | -306,000 | -2,130,000 |
| Financing Cash Flow | $1,316,000 | $-2,139,000 | $-654,000 | $-2,326,000 | $-1,440,000 |
| Exchange Rate Effect | 88,000 | -229,000 | -11,000 | 749,000 | 655,000 |
| Beginning Cash Position | 5,034,000 | 5,877,000 | 5,472,000 | 4,886,000 | -8,342,000 |
| End Cash Position | 6,121,000 | 5,034,000 | 5,877,000 | 5,472,000 | 4,886,000 |
| Net Cash Flow | $999,000 | $-614,000 | $416,000 | $-163,000 | $-295,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,081,000 | 1,763,000 | 1,736,000 | 2,138,000 | 2,176,000 |
| Capital Expenditure | -382,000 | -462,000 | -388,000 | -785,000 | -503,000 |
| Free Cash Flow | 1,699,000 | 1,301,000 | 1,348,000 | 1,353,000 | 1,673,000 |